The international success of an Italian family-based company that has been modernising the electromedical field for 40 years.
Brera Medical Technologies is a well-known reality within the anti-aging sector yet, to understand their international success, we need to look back at the three-generation family history of the Grattacasos. Attilio Grattacaso, the CEO, illustrates the past, present and future of a thriving company.
ANTI AGE Magazine (AA MAG): How was the company founded? How did it evolve?
Attilio Grattacaso: The company started with my grandfather, Attilio, known by us as “the founder”, who in 1983 decided to focus on electro-medical machines for physiotherapy. However, it was my father Giovanni, a very forward-thinking individual and a pioneer who, as a medical student, had the intuition to give a modern twist to the equipment, innovating the technologies, from the effectivness of the devices to their design. With my input, the company has gradually shifted the attention to anti-aging technology. Nowadays, Brera Medical has created the grounds to challenge its giants in the aesthetic sector in terms of the design and innovation of its devices.
AA Mag: What would you say was the company’s turning point?
A.G.: After having patented numerous devices for body and face treatments, in 2016 we ventured in the field of non-invasive microsurgery, with certified products, like the famous Plasmage®, which is the emblem of the strong scientific and technological background and commitment the company is investing in this field but above all, the proof we are in constant evolution to compete with and challenge laser treatments.
AA Mag: What are your patented technologies?
A.G.: Plasma is a highly accessible energy that was not easy to control. Through fractionation, we managed to make it controllable and safe for the treatment of more delicate areas such as the periorbital area or for the removal of benign lesions in dermatology. Our Fractional Plasma® innovation was shared with a worldwide network of 500 doctors and researchers, who constantly update and perfect these techniques.Another of our patented technologies is Diatermocontraction®, the only radiofrequency signal that induces muscle contraction and endogenous heat simultaneously. This innovation goes further than traditional EMS as we are able to catch all the fi bres of the muscles to strenghthen them and optimise the lymphatic drainage to have an effective result. By associating the heat of RF, this will also bring more oxygen and vascularisation in the tissues and it will boost the fibroblasts.
AA Mag: How does your company differ from other companies in the field?
A.G.: With 40 years of experience in physiotherapy and dermatology, we understood the need to work on different layers of the body from epidermis, dermis to muscles. Therefore, from the combination of our patented technologies we created Jovena®.
AA Mag: Jovena® is your new innovation, what makes it unique?
A. G.: Jovena is a total skin regeneration system that uses Facestim® powered by Diatermocontraction® and Fractional Plasma®, revolutionising how skin can be treated for signs of aging and making the device unique in its industry. Whereas, today, in aesthetics, the major trend is to freeze the muscles with injections or it is to focus on the epidermis, Faces-tim®, our latest concept, is the stimulating treatment of inner muscles. It delivers the first technique allowing you to work and restore the facial muscles whilst improving the texture and quality of the skin. Moreover, with Jovena’s Fractional Plasma, we created the latest generation of plasma treatments by targeting larger areas. This offers another option to the existing skin resurfacing methods, allowing anti-aging professionals to provide superior results for patients in less time and with shorter recovery periods.AA Mag: Who is behind your success?
A.G.: Brera Medical Technologies thrives from the skills of a compact team, from electronic and biomedical engineers to technicians specialised in design and prototyping; from pro-duction and marketing to the collaboration with scientists from Italian and foreign universities. Our vision and intuition is a re-sult of our dedicated in-house R&D hub Isola Research Lab, the engine of creation of all of our devices.
AA Mag: What is the secret behind your company and values?
A.G.: Being a family-based company gives us strong founda-tions to compete on the global market. By prioritising the attention to safety and effi cacy, the customer, the ability to understand the different phases of sales and assistance, our products have an outstanding reputation in more than 30 countries.
AA Mag: What does the future hold for Brera Medical?A.G.: We are always taking into account the need of our customers to be revolutionary and we will soon launch new exciting devices for 2023 so stay tuned and follow us on our socials to discover more.
ATTILIO GRATTACASO: Graduate in International Business in England, Attilio Grattacaso is the current CEO of Brera Medical Technologies, an Italian company that has been revolutionising the anti-aging field with innovative technologies such as Plasmage and Jovena.
More informations: https://www.breramedical.com/
